August 28, 2025

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant

August 28, 2025

Girl With Waterdrop-Like Papules: What’s Your Diagnosis?

A teenager with atopic dermatitis presented with several painless, flesh-colored papules limited to the trunk. Dermoscopy and biopsy show selective loss of elastic fibers after prior molluscum contagiosum. What’s your diagnosis?

Conexiant

August 22, 2025

Linear Hyperpigmentation After Chemotherapy: What's Your Diagnosis?

A 15-year-old girl developed distinctive, painless, whip-like streaks across her trunk and back after receiving combination chemotherapy for ovarian yolk sac tumor. What’s your diagnosis?

Conexiant

August 19, 2025

Biopsy Strategies to Improve Granuloma Detection in Crohn’s Disease

Researchers link biopsy size, number, lesion severity, and location to granuloma detection in Crohn’s disease.

Conexiant

August 19, 2025

‘Enough Is Enough’—But When?

How Bogalusa, Louisiana became a lens on the US gun violence epidemic—where race, poverty, policy, and profit converge and communities bear the cost.

KFF Health News

August 19, 2025

Evidence-Based Guidance for Managing Hemorrhoidal Disease

Highlights to guide treatment from lifestyle changes and phlebotonics, to office-based procedures and surgery for advanced or refractory cases.

Conexiant

August 18, 2025

FDA Approves New Indication for Wegovy

Accelerated approval granted to Wegovy for treatment of noncirrhotic metabolic dysfunction–associated steatohepatitis in adults with stage F2 to F3 fibrosis.

Conexiant

August 14, 2025

AI May Improve Radiologist Reports

Radiologists completed reports 15% faster without reducing diagnostic accuracy,

Conexiant

August 14, 2025

AI Spots One-Third of Missed Cancers, Study Shows

AI analyzes digital breast tomosynthesis images and localizes interval cancers in retrospective screening data.

Conexiant